Polybiomics
ActivePolybiomics enables simultaneous measurements of multiple cellular features from the same sample in real-time.
What it does
Polybiomics is offering a disruptive live cell analysis platform for drug discovery and development, enabling the use of a single-instrument to generate interlinked datasets through multimodal testing of a single sample under constant conditions. Our solution uses AI to create actionable insights and predict outcomes, saving time, costs, and protecting sample integrity.
Next to it in Healthcare and bio · Live cell analysis platform for drug discovery
- Great Bay Bio 大湾生物Plug and Play PnP 2025
By utilizing AI and other cutting-edge technologies, GBB aims to address the challenges of long timelines, high costs, and low success rates in drug development.
- AMPLY DiscoveryTechstars TS 2023
AMPLY Discovery — Turning the Dark Genome into Novel Medicines
- FluoSpheraSOSV SOSV IndieBio NY 05
Drug Discovery without animals
- PaulingPlug and Play PnP 2025
Next-generation molecular simulation platform for drug discovery.
- Radicle SciencePlug and Play PnP 2025
Radicle Science is a health tech trailblazer bringing clinical proof to natural products and wellness. Its proof-as-a-service platform combines AI, clinical trials, and crowdsourcing to generate rigorous data on the effects of wellness products on diverse populations—at unprecedented scale and speed
- Elnora AI, Inc.Plug and Play PnP 2025
Elnora is an AI co-pilot for biomedical lab protocols that learns from every experiment to accelerate drug discovery.
- CytodymeTechstars TS 2025
Cytodyme
- Ångström AIY Combinator S24
Gen AI molecular simulations that reproduce wetlab results